Frost & Sullivan: Escalating Costs of Drug Development Drive the Pharmaceutical Companies to Tap Opportunities in Emerging Markets

Contact:

Katja Feick

Corporate Communications – Europe

P: +49 (0) 69 7703343

E: [email protected]

http://www.frost.com

Twitter: twitter.com/frost_sullivan